DCBLD2 and cancer: For the first time, we performed a pan-cancer analysis of DCBLD2, and the results revealed a was a statistically significant association of DCBLD2 expression with pathological stage, prognosis, immune regulation, and chemotherapeutic and targeted drug sensitivity.